The Hill reports: The co-director of the White House’s “Operation Warp Speed” will not be required to divest his investments in pharmaceutical companies and will not be subject to federal disclosure rules, according to a decision by a government watchdog. Advocacy groups Public Citizen and Lower Drug Prices Now filed the complaint with the Department of Health and Human Services …
Read More »